Brief: Onxeo signs exclusive license agreement with Pint Pharma

Valerio Therapeutics SA

27/07/2016 17:01

July 27 (Reuters) - Onxeo SA  C4X.PA : 
    * Signs exclusive license agreement with Pint Pharma for 
commercialization of Beleodaq in PTCL in South America 
    * Onxeo to receive upfront payment, regulatory and 
commercial milestones, and sales royalties for a total deal 
value greater than USD 20 million 
 
Source text for Eikon:  ID:nBw2Gp9Qga  
Further company coverage:  C4X.PA  
 
 (Gdynia Newsroom:) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))